drug · antibody

dupilumab

Marketedupdated 2mo ago

by $REGN REGENERON PHARMACEUTICALS, INC.🔗 ChEMBL

Approved

annual revenue · 2024–2024peak $14.1B

community read0 votes

Antibody drug with a maximum clinical stage of Approval (across all indications), with 8 approved and 30 investigational indications.

indications

investigational

Asthma

Interleukin-4 receptor subunit alpha

approval · 31

pdufa · 1

phase 2 completion · 1

Sanofi posts upbeat sales as R&D pressure builds
<figure><div><img src="https://imgproxy.divecdn.com/4sV6C1TzSj2YZ2rz0W5-EST8xmsio5JNKmZoYu-be_8/g:nowe:0:87/c:520:294/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…
biopharma_dive · 2mo ago